by Don McLean | Aug 27, 2020 | Blog
How Zero Contact GXP Audits Ensure Compliance While Protecting Auditors and Auditees during the Global Pandemic by Staff Writer Remote audits are crucial for auditors and auditees in the pharmaceutical industry to help reduce health risks since the advent of the...
by Don McLean | Jun 27, 2019 | Blog
Pharmaceutical Industry News Roundup: June 2019 by Staff writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on: FDA ‘open for business’ in considering real-world evidence,...
by Don McLean | Apr 4, 2019 | Blog
Part 4: The Case for Better Health History Records – Overcoming Barriers to Medical Records Access by Barbara Rusin In Part 3 of this medical histories series, the focus centered on defining many of the barriers that clinical investigators face when attempting to...
by Don McLean | Mar 7, 2019 | Blog
Part 3: The Case for Better Health History Records – Identifying Barriers to Access by Barbara Rusin In Part 2 of this series, the focus was on ensuring adequate information to support subject eligibility. Knowing how many and what kinds of records to review is key to...
by Don McLean | Feb 21, 2019 | Blog
Part 2: The Case for Better Health History Records – How Much History is Needed and How Should it be Reviewed? by Barbara Rusin Part 1 of this medical histories series focused on the regulations relevant to clinical trial subject eligibility, and the possible issues...
